Role of Omalizumab in Children With Difficult to Control Asthma
Omalizumab is a humanized monoclonal antibody used in the treatment of moderate to severe allergic asthma in children over 12 years and adults. There are many adult studies that have shown it to be a safe drug. The adult clinical trials show improvement in clinical outcomes for patients on omalizumab but reports on its real-life use in children are few. Additional studies for the use of omalizumab in pediatric population are needed. The aim of this paper is to review the limited pediatric literature and compare with a retrospective chart review done for pediatric patients taking omalizumab at a tertiary pulmonary clinic with moderate to severe allergic asthma. A review of the recent pediatric studies was compared with a retrospective chart review on all patients prescribed Xolair (omalizum...